Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis

Circulation. 2004 Jan 20;109(2):220-6. doi: 10.1161/01.CIR.0000109141.48980.37. Epub 2003 Dec 22.

Abstract

Background: The molecular mechanisms by which physical training improves peripheral and coronary artery disease are poorly understood. Bone marrow-derived endothelial progenitor cells (EPCs) are thought to exert beneficial effects on atherosclerosis, angiogenesis, and vascular repair.

Methods and results: To study the effect of physical activity on the bone marrow, EPCs were quantified by fluorescence-activated cell sorter analysis in mice randomized to running wheels (5.1+/-0.8 km/d, n=12 to 16 per group) or no running wheel. Numbers of EPCs circulating in the peripheral blood of trained mice were enhanced to 267+/-19%, 289+/-22%, and 280+/-25% of control levels after 7, 14, and 28 days, respectively, accompanied by a similar increase of EPCs in the bone marrow and EPCs expanded from spleen-derived mononuclear cells. eNOS-/- mice and wild-type mice treated with N(G)-nitro-l-arginine methyl ester showed lower EPC numbers at baseline and a significantly attenuated increase of EPC in response to physical activity. Exercise NO dependently increased serum levels of vascular endothelial growth factor and reduced the rate of apoptosis in spleen-derived EPCs. Running inhibited neointima formation after carotid artery injury by 22+/-2%. Neoangiogenesis, as assessed in a subcutaneous disc model, was increased by 41+/-16% compared with controls. In patients with stable coronary artery disease (n=19), moderate exercise training for 28 days led to a significant increase in circulating EPCs and reduced EPC apoptosis.

Conclusions: Physical activity increases the production and circulating numbers of EPCs via a partially NO-dependent, antiapoptotic effect that could potentially underlie exercise-related beneficial effects on cardiovascular diseases.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Animals
  • Apoptosis
  • Arterial Occlusive Diseases / pathology
  • Arterial Occlusive Diseases / prevention & control*
  • Bone Marrow Cells / cytology
  • Cells, Cultured
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / therapy
  • Endothelium, Vascular / cytology*
  • Exercise Therapy*
  • Female
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neovascularization, Physiologic*
  • Nitric Oxide / physiology
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Physical Conditioning, Animal
  • Stem Cells / cytology*
  • Tunica Intima / pathology
  • Vascular Endothelial Growth Factor A / biosynthesis

Substances

  • Vascular Endothelial Growth Factor A
  • Nitric Oxide
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse